Resolution criteria

This market will resolve to "Yes" if Until Labs announces a formal commitment to attempt the cryopreservation of Ben Sasse, or if there is documented evidence that Ben Sasse has entered a formal arrangement for cryopreservation services with Until Labs. Otherwise, this market will resolve to "No".

Relevant announcements would be expected via official press releases, reputable media outlets, or verified public statements from Until Labs or representatives of Ben Sasse.

Background

Until Labs is a biotech company focused on developing reversible cryopreservation technology, specifically targeting organ-scale applications to improve transplantation and medical care. The company, formerly known as Cradle Healthcare, conducts research into cryoprotectants and rewarming protocols.

Ben Sasse is a former U.S. Senator from Nebraska and former president of the University of Florida. In December 2025, Sasse publicly announced that he had been diagnosed with terminal Stage 4 pancreatic cancer. As of April 2026, he has reported ongoing health challenges related to his condition and its treatment.

This description was generated by AI. Review and verify everything here yourself. You can edit, replace, or delete any part of this description, including the resolution criteria. You do not need to trust the AI output.